Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC
- Status
- TERMINATED
- Phase
- PHASE3
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
MicroRNA Profiles in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of AZD2811 + Durvalumab in ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2